Necrotizing enterocolitis in premature infants—A defect in the brakes? Evidence from clinical and animal studies

Overview of mechanisms from mouse and human studies that reveal how “the brakes on TLRs” are established in the neonatal gut. (1) Human milk components such as lactoferrin and secretory IgA inhibit growth of pathogenic microbes that can activate TLR signaling. (2) Epidermal growth factor and glutamine in breastmilk enhance intestinal epithelial barrier by inducing mucin production and tight junction protein activity. (3) HMOs present in human milk promote growth of commensal microbes such as Bifidobacteria and Lactobacillus. (4) The intestinal epithelial barrier—which includes mucin, antimicrobial peptides, and tight junction proteins—acts as a physical barrier that separates pathogenic microbes from the developing gut. (5) SCFAs, produced in part from the fermentation of HMOs by commensal bacteria, induce mucosal mechanisms such as increased mucin production to help repress intestinal TLR sensitivity. (6) Commensals such as Bifidobacterium and Lactobacillus, whose growth was promoted in part by HMOs, induce negative regulators of TLR4 (SIGIRR, A20, TOLLIP) to suppress TLR4 activity in the gut. (7) Development of postnatal tolerance to LPS through reduced surface TLR4 expression and repression of IRAK1. (8) Postnatal induction of genes that inhibit intestinal TLR signaling (SIGIRR, A20, TOLLIP) helps prevent aberrant intestinal TLR activation to colonizing microbes. (9) Postnatal repression of IRAK1 through SIGIRR-STAT3-miR-146a pathway dampens TLR4 signaling and contributes to LPS tolerance. (10) Developmental increase in IκB sequesters NFκB in the cytoplasm preventing its transcriptional activation. (11) Compartmentalization of TLRs in the basolateral membrane of IECs decreases TLR activation from bacteria in the apical lumen. HMOs = human milk oligosaccharides; IEC = intestinal epithelial cell; Ig = immunoglobulin; LPS = lipopolysaccharide; NEC = necrotizing enterocolitis; SCFAs = Short-chain fatty acids; Th = T helper; TLR = toll-like receptor.
Necrotizing enterocolitis in premature infants—A defect in the brakes? Evidence from clinical and animal studies

Publication

Necrotizing enterocolitis in premature infants—A defect in the brakes? Evidence from clinical and animal studies. (2023) Venkatesh Sampath, et al. Mucosal Immunol. ;16(2):208-220. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates IgA IGA ncbigene_synonym CD79A 973
Homo sapiens Primates Mucin MUCIN ncbigene_synonym MUC5AC 4586
Homo sapiens Primates SIGIRR SIGIRR ncbigene_symbol SIGIRR 59307
Homo sapiens Primates A20 A20 ncbigene_synonym TNFAIP3 7128
Homo sapiens Primates A20 A20 ncbigene_synonym IGKV1-27 28935
Homo sapiens Primates TOLLIP TOLLIP ncbigene_symbol TOLLIP 54472
Homo sapiens Primates MyD88 MYD88 ncbigene_symbol MYD88 4615
Homo sapiens Primates IRAK1 IRAK1 ncbigene_symbol IRAK1 3654
Homo sapiens Primates IKBB IKBB ncbigene_synonym NFKBIB 4793
Homo sapiens Primates LPS LPS ncbigene_synonym IRF6 3664
Homo sapiens Primates TLR4 TLR4 ncbigene_symbol TLR4 7099
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates (miR-146a) MIR146A ncbigene_symbol MIR146A 406938
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates TLR2 TLR2 ncbigene_symbol TLR2 7097
Homo sapiens Primates TLR5 TLR5 ncbigene_symbol TLR5 7100

Chemical mentions

Word Match MeSH Name ChEBI
Lactoferrin NA mesh:C432397
Glutamine Arg-Gln mesh:C578860 arginyl-glutamine chebi:73813
Mo Molybdenum mesh:D008982 molybdenum atom chebi:28685

Disease mentions

Word Match MeSH Name DOID
LPS Van der Woude syndrome mesh:C536528 Van der Woude syndrome doid:0060239